Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions

doi:10.12998/wjcc.v7.i21.3394

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7362)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

355

WORD

151

HTML

2516

Figures (1-3)

270

Tables (1-2)

264

Sum=3556

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

591

Download

1010

Sum=1601

Publishing Process of This Article

Item

Count

Browse

715

Download

1490

Sum=2205

Nov 6, 2019 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Nov 6, 2019; 7(21): 3394-3406
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3394

Open in New Tab Full Size Figure Download Figure

Figure 1 Underlying cause of the secondary haemophagocytic lymphohistiocytosis according to the age of patients.

Open in New Tab Full Size Figure Download Figure

Figure 2 Management of 80 patients with secondary haemophagocytic lymphohistiocytosis. LAMB: Liposomal amphotericin B; IVIG: Intravenous γ-immunoglobulin.

Open in New Tab Full Size Figure Download Figure

Figure 3 Comparison of patients’ survival according to the age group (log rank test x² = 8. 510, P = 0.01).

Citation: Georgiadou S, Gatselis NK, Stefos A, Zachou K, Makaritsis K, Rigopoulou EI, Dalekos GN. Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions. World J Clin Cases 2019; 7(21): 3394-3406
URL: https://www.wjgnet.com/2307-8960/full/v7/i21/3394.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i21.3394